This study also showed a non-significant 17% reduction in albuminuria.67 The AWARD-7 study analyzed the efficacy of dulaglutide in patients with DM2 and moderate-severe CKD (mean eGFR 38 ml/min/1.73 m2)
But following the clearance of oral GLP-1s, accessibility and ease of use are a hot topic of discussion
A slight reduction in blood pressure has also been observed in SUSTAIN-6 and LEADER trials [53, 54]
Disclosures: Mansoor Rahman: Nothing to Disclose, FNU Khalil Ur Rehman: Nothing to Disclose, Fatima Usama: Nothing to Disclose, Khawaja Hassam: Nothing to Disclose, Rohullah Rasikh: Nothing to Disclose, Syed Bilal Shah: Nothing to Disclose, Ashraf Ullah: Nothing to Disclose, Zabeeh Ullah: Nothing to Disclose, Abu baker Khan: Nothing to Disclose, Daryl Lau: Gilead: Grant/Research Support, GSK: Consultant, Abbott Laboratories: Consultant 457 DISTRIBUTION OF CIRCULATING T FOLLICULAR HELPER 17 CELL SUBSETS ALTERED IN CHB PATIENTS Shengxia Yin 1 Qi Gu 1 Minxin Mao 1 Chao Wu 1 Jie Li 1 , 1 Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University Background: Hepatitis B virus (HBV)-specific B cell dysfunction is associated with failure of functional cure in chronic hepatitis B (CHB)
Do not add any amount of any type of milk or creamer